KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ginkgo Bioworks Holdings (DNA) Return on Equity (2021 - 2025)

Historic Return on Equity for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Q3 2025 value amounting to 0.58%.

  • Ginkgo Bioworks Holdings' Return on Equity rose 2200.0% to 0.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.58%, marking a year-over-year increase of 2200.0%. This contributed to the annual value of 0.6% for FY2024, which is 300.0% up from last year.
  • As of Q3 2025, Ginkgo Bioworks Holdings' Return on Equity stood at 0.58%, which was up 2200.0% from 0.5% recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Return on Equity registered a high of 0.28% during Q3 2021, and its lowest value of 2.35% during Q3 2022.
  • Over the past 5 years, Ginkgo Bioworks Holdings' median Return on Equity value was 0.79% (recorded in 2023), while the average stood at 0.93%.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Return on Equity plummeted by -20600bps in 2022, and later skyrocketed by 17300bps in 2023.
  • Quarter analysis of 5 years shows Ginkgo Bioworks Holdings' Return on Equity stood at 1.15% in 2021, then dropped by -15bps to 1.32% in 2022, then skyrocketed by 43bps to 0.76% in 2023, then increased by 5bps to 0.72% in 2024, then grew by 20bps to 0.58% in 2025.
  • Its Return on Equity was 0.58% in Q3 2025, compared to 0.5% in Q2 2025 and 0.69% in Q1 2025.